GlassScriptPhysician profile
Andrew A Win
NPI 1710931712
$11,919.49
in general payments reported to CMS, 2019-2025
51 companies · $1,248 in 2025
The $1,248 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,456 · 2020: $1,321 · 2021: $2,030 · 2022: $2,401 · 2023: $1,745 · 2024: $1,719 · 2025: $1,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,677 · Education: $34.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,677.40 |
| Education | $34.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,304.39 | 2019-2024 | Xarelto, Uptravi |
| Actelion Pharmaceuticals US, INC. | $1,019.76 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Novartis Pharmaceuticals Corporation | $965.00 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $882.30 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $831.03 | 2019-2025 | Repatha |
| Sanofi-Aventis U.S. LLC | $753.80 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $750.40 | 2021-2025 | Verquvo, Capvaxive, Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $584.82 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $500.95 | 2019-2025 | Brilinta |
| Amarin Pharma, INC. | $465.79 | 2019-2022 | |
| Novo Nordisk INC | $381.73 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $376.18 | 2019-2023 | Mitraclip, Cardiomems |
| Bayer Healthcare Pharmaceuticals INC. | $277.63 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $276.17 | 2019-2025 | Lifevest |
| Pfizer INC. | $261.74 | 2019-2025 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $225.75 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| United Therapeutics Corporation | $217.91 | 2022-2025 | Tyvaso, Tyvaso, Orenitram |
| Daiichi Sankyo INC. | $158.10 | 2021-2024 | Injectafer |
| Kowa Pharmaceuticals America, INC. | $151.48 | 2019-2024 | Livalo |
| Medtronic, INC. | $141.30 | 2022-2024 | Corevalve Evolut R |
| Esperion Therapeutics, INC. | $136.80 | 2020-2021 | |
| Baxter Healthcare | $132.24 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Scpharmaceuticals INC. | $107.84 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $87.32 | 2022-2025 | Amvuttra, Onpattro |
| Providence Medical Technology, INC. | $86.75 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $68.47 | 2024 | |
| Edwards Lifesciences Corporation | $62.41 | 2019-2023 | Sapien 3 Ultra Resilia |
| Lundbeck LLC | $57.57 | 2020 | |
| Arbor Pharmaceuticals, INC. | $55.09 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $52.03 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $51.93 | 2021-2023 | Cardiva Vascade 6/7f Vcs |
| Kiniksa Pharmaceuticals, LTD. | $50.45 | 2021-2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $49.83 | 2019 | |
| Medicomp INC | $48.33 | 2022-2024 | Telepatch Cardiac Monitor |
| Bridgebio Pharma, INC. | $41.39 | 2025 | Attruby |
| Azurity Pharmaceuticals, INC. | $41.32 | 2025 | Edarbi |
| Boston Scientific Corporation | $40.80 | 2019-2020 | |
| Cvrx, INC. | $34.03 | 2022-2025 | Barostim Neo System |
| Vital Connect, INC | $20.47 | 2025 | Vitalpatch Rtm |
| Genzyme Corporation | $19.07 | 2019 | |
| Solventum Corporation | $16.55 | 2025 | Promogran Prisma, Activ.A.C. |
| G Medical Diagnostic Services, INC. | $14.67 | 2022 | |
| Biotronik INC. | $14.67 | 2019 | |
| Vifor Pharma, INC. | $14.61 | 2019 | |
| Tactile Systems Technology INC | $13.80 | 2019 | |
| Lemaitre Vascular, INC. | $13.66 | 2019 | |
| Allergan, INC. | $13.18 | 2019 | |
| Astellas Pharma US INC | $13.04 | 2020 | |
| Vivaquant INC, Dba Rhythm Express | $12.42 | 2024 | Rhythm Express |
| Gilead Sciences, INC. | $11.38 | 2019 | |
| Sun Pharmaceutical Industries INC. | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Win listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.